Literature DB >> 27255581

Reply to "Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing".

Maria Reig1, Ferran Torres2, Zoe Mariño3, Xavier Forns3, Jordi Bruix4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27255581     DOI： 10.1016/j.jhep.2016.05.036

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.

Authors:  Giuliano Ramadori; Patrizia Bosio; Federico Moriconi; Ihtzaz A Malik
Journal:  BMC Cancer       Date:  2018-03-06       Impact factor: 4.430

2.  Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C.

Authors:  Chung Sang Tse; Ju Dong Yang; Omar Y Mousa; Kevin M Nelson; Surakit Pungpapong; Andrew Keaveny; Bashar A Aqel; Hugo Vargas; Rolland C Dickson; Kymberly Watt; Gregory J Gores; Lewis R Roberts; Michael D Leise
Journal:  Transplant Direct       Date:  2020-12-08

Review 3.  Hepatitis C Virus Structure: Defined by What It Is Not.

Authors:  Altaira D Dearborn; Joseph Marcotrigiano
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 6.915
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.